Idarubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Nizatidine Manufacturers of Nizatidine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Nizatidine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 30 mg/m230 (30)24 hourlyDaily for 3 day for leukemia.45 mg/m245 (45)24 hourlyFor reftractory breast cancer.12 mg/m sq.22 (22)24 hourlySlow IVOver 10-15 minutes. Paedriatic Dosage (20kg) 45 mg/m245 (45)As recommended.For 3 days. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Nizatidine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Nizatidine Back to top Manufacturers of Idarubicin (HCl) in Pakistan Al-Habib Pfizer Back to top Previous Drug Generic - Next Drug Generic
Idarubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Nizatidine Manufacturers of Nizatidine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Nizatidine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 30 mg/m230 (30)24 hourlyDaily for 3 day for leukemia.45 mg/m245 (45)24 hourlyFor reftractory breast cancer.12 mg/m sq.22 (22)24 hourlySlow IVOver 10-15 minutes. Paedriatic Dosage (20kg) 45 mg/m245 (45)As recommended.For 3 days. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Nizatidine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Nizatidine Back to top Manufacturers of Idarubicin (HCl) in Pakistan Al-Habib Pfizer Back to top Previous Drug Generic - Next Drug Generic